Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma
- PMID: 8610052
- DOI: 10.1002/(SICI)1097-0045(199605)28:5<275::AID-PROS1>3.0.CO;2-B
Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma
Abstract
Loss of heterozygosity (LOH) at chromosomal loci has been associated with the presence of tumor suppressor genes at the deleted loci. Twenty-six clinically localized, Stage B prostate carcinomas were analyzed for LOH on chromosomes 10 and 17 using microsatellite markers. Two of 26 carcinomas showed LOH on 17p while one showed LOH on 17q. Chromosome 10 showed a complex pattern of LOH with monosomy (1 case), LOH on 10p (1 case), proximal 10q (1 case) and distal 10q (2 cases). Overall 29% of informative cases showed LOH on chromosome 10. These results are consistent with the presence of a tumor suppressor for prostate cancer on 17p and multiple tumor suppressor genes on chromosome 10.
Similar articles
-
Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.Cancer Res. 1997 Mar 15;57(6):1058-62. Cancer Res. 1997. PMID: 9067271
-
Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.Prostate. 2002 Sep 15;53(1):60-4. doi: 10.1002/pros.10131. Prostate. 2002. PMID: 12210480
-
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.Cancer Res. 1995 Mar 1;55(5):1002-5. Cancer Res. 1995. PMID: 7866981
-
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.Adv Exp Med Biol. 1997;407:41-53. doi: 10.1007/978-1-4899-1813-0_7. Adv Exp Med Biol. 1997. PMID: 9321930 Review.
-
Genetic changes associated with prostate cancer in humans.Cancer Surv. 1991;11:15-24. Cancer Surv. 1991. PMID: 1841750 Review.
Cited by
-
Genetics of prostate cancer.Clin Med Res. 2003 Jan;1(1):21-8. doi: 10.3121/cmr.1.1.21. Clin Med Res. 2003. PMID: 15931281 Free PMC article.
-
Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.J Histochem Cytochem. 2013 Sep;61(9):659-70. doi: 10.1369/0022155413495875. Epub 2013 Jun 12. J Histochem Cytochem. 2013. PMID: 23761130 Free PMC article.
-
Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.Jpn J Cancer Res. 1998 Jan;89(1):17-21. doi: 10.1111/j.1349-7006.1998.tb00473.x. Jpn J Cancer Res. 1998. PMID: 9510470 Free PMC article.
-
Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).Am J Pathol. 1999 Sep;155(3):967-71. doi: 10.1016/S0002-9440(10)65196-6. Am J Pathol. 1999. PMID: 10487854 Free PMC article.
-
Toward Systems Pathology for PTEN Diagnostics.Cold Spring Harb Perspect Med. 2020 May 1;10(5):a037127. doi: 10.1101/cshperspect.a037127. Cold Spring Harb Perspect Med. 2020. PMID: 31615872 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical